Acute Myeloid Leukemia (AML) is a hematological malignancy characterized by the rapid, uncontrolled growth of immature myeloid cells, leading to bone marrow ...

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Brice and Amanda Dieter of Jamestown had their figurative worlds upended in October 2023. It was at this time that the ...

First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable Disease Reports Continued Patient Progress from Phase ...

Acute lymphocytic leukaemia (ALL ... ALL is the most common type of cancer in children and can also occur in adults. Recent data from the FELIX trial evaluating obecabtagene autoleucel in patients ...

In conclusion, although age should generally determine the goal of treatment in CLL ... of chronic lymphocytic leukemia (CLL) is dramatically increased in elderly patients although knowledge ...

HOUSTON - Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company with a market capitalization of $3.1 million, has announced continued progress in its clinical trials for cancer treatments.

According to the American Cancer Society, rates of leukemia — particularly acute myeloid leukemia ... disease-related immunosuppression, and treatment-related immunosuppression.

No writing assistance was utilized in the production of this manuscript. Arterial hypertension in the elderly is a major health economy burden. Systolic hypertension is an expression of increased ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...